BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs4950928
,
EGFR
,
calcium channel activity
,
Arthritis
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
EZH2 protein
Summary
General Info
Curated Studies
Most Correlated Studies
NF-kB and EZH2 gene regulation in breast cancers
Expression data from mouse ES cells and various differentiated cell types
Embryonic stem cells and the role of polycomb group genes (SUZ12, RING, EZH2) during differentiation
Mammary gland development in EZH1 and EZH2 mutant mice
Prostate cancer cell line (LNCaP) treated with trichostatin A or roscovitine, or EZH2 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
EZH2 controls epicardial cell migration during heart development.
Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader.
A patent review of EZH2 inhibitors from 2017 and beyond.
Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases.
EZH2 serves as a promising therapeutic target for fibrosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From F…
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ